Location: Home
  • search
  • go
  • Relate News
  • 12/10/2024China Biopharma Tracker – November 2024 (PharmaDJ)
  • 12/10/2024How Wholly Foreign-Owned Hospitals Can Help China's Health Care Sector...
  • 12/10/2024The New Draft Administrative Measures For Management Of Medical Repres...
  • 12/9/2024CDE Publicizes the List of Reference Formulations for GQCE Studies (89...
  • 12/9/2024Nicox Launches Zerviate in China thru OcuMension Therapeutics
  • 12/9/2024CStone Unveils Promising Clinical Data on CS5001 for Advanced Lymphoma...
  • 12/9/2024Belief Biomed Unveils Promising Gene Therapy Data at ASH 2024
  • 12/9/2024Hengrui Medicine to Issue H-Shares and Pursue Hong Kong Main Board Lis...
  • 12/9/2024Domestic Pharma Cos Poised to Gain in Chinese GLP-1 Obesity Drug Marke...
  • 12/8/2024BioNTech and DualityBio Unveil Promising Interim Results for Partnered...
  • 12/8/2024ChipScreen Announces Mixed Phase III Results for Chiauranib in SCLC Tr...
  • 12/6/2024Implications of China's Growing Influence in Global Pharma / API Suppl...
  • 12/6/2024China's Expanding Proton Therapy Market: Key Drivers
  • 12/6/2024Medical Costs in Mainland China and Hong Kong to Grow More Slowly Than...
  • 12/6/2024CDE Seeks Comments on Draft ICH Guidelines M15
  • 12/6/2024Recent Executive Moves
  • 12/5/2024Abbisko’s PRMT5*MTA Inhibitor ABSK131 Granted IND Clearance from the ...
  • 12/5/2024Cinclus Wins Marketing Approval in China for GERD Drug Linaprazan Glur...
  • 12/5/2024SK Biopharm Advances Epilepsy Treatment in China with NDA Submission ...
  • 12/5/2024GSK and Zhifei Deepen Collaboration to Target RSV Vaccine Development
  • 12/5/20242025 Trends Buoying Boom Phase in APAC (Biospectrum)
  • 12/5/2024Big Pharma Doubles Down on China (The Wire China)
  • 12/4/2024CDE Issues the List of Reference Formulations for GQCE Studies (85th B...
  • 12/4/2024Everest Medicines Announces Positive Results in Preliminary Analysis o...
  • 12/4/2024GSK Secures $1B Option Deal for DualityBio's Preclinical ADC
  • 12/3/2024CMS Gains Licenses Class 1 New Drug Targeting Gout and Hyperuricemia f...
  • 12/3/2024Sanofi Allocates €1 Billion for New Insulin Manufacturing Facility in...
  • 12/3/2024NHC Minister Meets with Sanofi and BioMérieux Bosses to Strengthen Si...
  • 12/3/2024PharmaMar/Luye's Lurbinectedin Gains Approval in China for Treating Me...
  • 12/3/2024Signet Thera Secures Over CNY 70M to Advance Targeted Cancer Drug Deve...
  • Page:22/761 Total number of articles:22823: [First][<<] [20] [21] [22] [23] [24] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group